Compare Colgate-Palmolive Company (CL) vs Nike Inc (NKE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Colgate-Palmolive Company vs Nike Inc — how do they compare? Colgate-Palmolive Company trades at $91.1 (market cap $72.84B), while Nike Inc trades at $42.98 (market cap $63.47B). The key difference: Colgate-Palmolive Company and Nike Inc are close in size by market cap, and Nike Inc pays the higher dividend (3.83%). Which is the better fit depends on your goals.
| CL | NKE | |
|---|---|---|
Market Cap | $72.84B | $63.47B |
Sector | Consumer Staples | Consumer Cyclical |
52-Week High | $99.14 | $79.24 |
52-Week Low | $74.98 | $40.75 |
Enterprise Value | $79.48B | $65.48B |
Dividend Yield | 2.33% | 3.83% |
Volume | — | 8,887,180 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Colgate-Palmolive (CL) trades at $93.21, up 1.05% with a bullish technical signal and consistent earnings beats. The stock shows strong profitability with 60.06% gross margins and 822.05% ROE, though valuation metrics appear elevated with a P/E of 36.13. Recent dividend declarations and positive analyst coverage (42% buy rating) support the defensive stock's appeal amid market rotation into stable cash flow names.
Outlook remains positive with a $97 consensus price target representing 4% upside, though premium valuation and North American segment softness present headwinds. The company's 64-year dividend growth streak and global diversification provide stability, while inflation pressures and competitive threats require monitoring for sustained outperformance.
Nike (NKE) trades at $42.86, down 3.4% on the day, as the stock faces pressure from recent earnings volatility and competitive challenges. The company maintains strong brand recognition with a gross margin of 42.91% and ROE of 22.14%, but revenue declined to $46.31B in 2025 with net income margin compression to 6.7%. Technical indicators show a bullish moving average signal with neutral oscillators, while analyst consensus remains positive with a $50.80 price target representing 18.5% upside potential.
Nike's investment case balances strong profitability metrics against recent revenue headwinds. The stock offers potential upside to analyst targets but faces execution risks in China and EMEA markets, inventory management challenges, and margin pressure from promotional activity. Q2 2026 earnings due June 30 will be critical for validating the company's turnaround strategy and growth trajectory.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Colgate-Palmolive Company
Since its founding in 1806, Colgate-Palmolive has grown to become a leading global consumer product company. In addition to its namesake oral care line, the firm manufactures shampoos, shower gels, deodorants, and home care products that are sold in over 200 countries (international sales account for about 70% of its consolidated total, including approximately 45% from emerging regions). It also owns specialty pet food maker Hill's, which sells its products through veterinarians and specialty pet retailers.
Read more on CL →About Nike Inc
NIKE, Inc. designs, develops, and markets athletic footwear, apparel, equipment, and accessory products for men, women, and children. The Company sells its products worldwide to retail stores, through its own stores, subsidiaries, and distributors.
Read more on NKE →
